Navigation Links
Rutgers scientist receives prestigious 'Young Investigator Award'
Date:6/17/2008

f the postpartum female which have evolved to maximally benefit the survival of offspring. In humans, cocaine use is not compatible with good parental care, and motivation to seek cocaine competes negatively with the motivation to care for offspring. Such impaired parental care can lead to harm to infants, with the possibility of lifelong consequences."

"As Dr. Pereira expands her experimental and scholarly repertoire using cutting-edge neuroscience approaches, she will have the strongest possible experiences for further growth in her scientific skills, and leadership in her field," noted Morrell.

Pereira received undergraduate and graduate degrees from the University of Uruguay in Montevideo-Uruguay, completing her Ph.D. in biological sciences, with honors in physiological sciences in 2006.

Prior to working in Morrell's lab, she conducted research at the University of Uruguay in Montevideo-Uruguay, the University of Connecticut and at the Center for Research and Advanced Studies in Mexico. She is a co-author of numerous articles, published in Pharmacology Biochemistry and Behavior, Physiology and Behavior, Psychopharmacology, Behavioral Brain Research, and other academic journals.


'/>"/>

Contact: Helen Paxton
paxton@andromeda.rutgers.edu
Rutgers University
Source:Eurekalert

0

GOOD

Page: 1 2

Related medicine news :

1. Rutgers College of Nursing faculty member Rachel Jones wins New York Times Nurse Award
2. Rutgers biomaterial debuts in clinical trials of new stent
3. N.J. nurses are overworked according to Rutgers College of Nursing professor
4. Rutgers College of Nursing emerita professor Beverly Whipple receives FSSS book award
5. Rutgers College of Nursing faculty member Rachel Jones awarded Rutgers-Newark Provost Award
6. Rutgers center sparks liquid bandage, a new frontline wound treatment
7. NJSNA honors Rutgers College of Nursings Linda Flynn for excellence in research
8. Rutgers researchers unlock mysteries of vitamin A metabolism during embryonic development
9. Julia Quinlan to present awards at a conference hosted by Rutgers College of Nursing
10. The Zonta Club of Essex County honors Rutgers College of Nursings Rachel Jones
11. Rutgers research partner Stemcyte, Inc., expands to New Jersey
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/7/2009)...c. (NYSE: WLP ) announced,today that senior mana...J.P.,Morgan Healthcare Conference on Jan. 12, 2009...astern Standard Time). , WellPoint, Inc. is sc...months ended Dec. 31, 2008, on January 28, 2009. W...r to this scheduled earnings release, and therefor...
(Date:1/7/2009)...ises, Inc. (BME), a cutting edge medical device co...mory metal implants, announced today that it has a...f Executive Officer. W. Casey Fox, PhD, P.E., BME...nd continue to focus his efforts on building BME,s...es in nitinol implants that contract and compress ...
(Date:1/7/2009)...the troubles of those born at 39 weeks, , ...ng an elective repeat C-section should wait until ...have the baby, if there are no medical issues with...ing just two weeks earlier doubles the risk that t...ing, infection and low blood sugar, according to t...
(Date:1/7/2009)...known as Emily,s Law, has received Governor Ted St...l in the state of Ohio. Named after Emily Jerry, E...gulations for pharmacy technicians. The law, which... was drafted with assistance of the National Pharm... Emily Jerry died at the age of two as the result ...
Breaking Medicine News(10 mins):Health News:WellPoint Announces Appearance at Upcoming Conference 2Health News:BioMedical Enterprises, Inc. (BME) Announces the Appointment of Kenneth I. Moch as President and Chief Executive Officer 2Health News:Early Elective C-Sections Produce Complications 2Health News:Early Elective C-Sections Produce Complications 3Health News:Emily's Law for Regulating Pharmacy Technicians Signed by Ohio Governor 2Health News:Emily's Law for Regulating Pharmacy Technicians Signed by Ohio Governor 3
... aside promises of slimmer portions and healthy me...ze version// of the Big Mac, now to be made 40 per...sized burger, expected to contain at least 690 cal...orld Cup promotion for the summer. Vigorous advert...
...offering "bloodless surgery" to almost 90% of its ...now joins an ever-growing number of hospitals that...ne around the country. This option was once only ...is now provided in certain hospitals to more patie...
...d hence various organizations are putting in their...nizations are working towards the complete eradica...One such step is taken by the Manipur AIDS Control...al organizations (NGOs) who are thriving day and n...
...dical negligence, surgeons have reported the remov...ide the patient's abdomen three years ago//. The f...r old Pakistani patient while she had underwent ap...consisting of three senior surgeons and four param...
Other Medicine News:
(Date:1/5/2009)...lene Pharmaceuticals announced today that it has i...protein kinase inhibitor, CX-4945, in patients wit...ultiple myeloma. The primary endpoints of the oral..., tolerance and PK properties of CX-4945 and to se...addition, multiple mechanism-related pharmacodynam...
(Date:12/30/2008)...wswire/ -- The Coalition for 21st Century Medicine...nentech, Inc. on December 5, 2008, seeking to rest...ic tests to physicians and patients. The request ...rm patient care and rests on flawed scientific and... to encourage the research, development, and comme...
(Date:12/27/2008)...lence, offers to ease cloning costs for Clonaid cl...27 Six years to the day...ld, Dr. Brigitte Boisselier, head of the company t...babies cloned by her company are growing up health...lies, privacy. , , "We,ve helped almost 100 fam...
(Date:12/17/2008)...-- PEAK Surgical, Inc., a medical,device company ...based on a,proprietary technology, announced toda...) has granted the company 510(k) clearance to mark...gulation of soft tissue during,plastic and recons...,orthopedic, arthroscopic, spinal and neurologica...
Breaking Medicine Technology:Cylene Pharmaceuticals Initiates Phase I Trial With CX-4945 -Breakthrough First-in Class Inhibitor of CK2 2Cylene Pharmaceuticals Initiates Phase I Trial With CX-4945 -Breakthrough First-in Class Inhibitor of CK2 3Coalition for 21st Century Medicine Issues Statement in Opposition of Genentech Petition to Restrict Lab Use of Diagnostic Tests for Physicians and Patients 2Coalition for 21st Century Medicine Issues Statement in Opposition of Genentech Petition to Restrict Lab Use of Diagnostic Tests for Physicians and Patients 3Coalition for 21st Century Medicine Issues Statement in Opposition of Genentech Petition to Restrict Lab Use of Diagnostic Tests for Physicians and Patients 4'We're Ready to Prove It!' 2PEAK Surgical Receives 510(k) Clearance to Market PEAK(R) Surgery System for Use in Expanded Indications 2PEAK Surgical Receives 510(k) Clearance to Market PEAK(R) Surgery System for Use in Expanded Indications 3PEAK Surgical Receives 510(k) Clearance to Market PEAK(R) Surgery System for Use in Expanded Indications 4New Method Better Predictor of In Vitro Fertilization Success 23077 1New Method Better Predictor of In Vitro Fertilization Success 23077 2Death Rates for HIV Patients Decrease Dramatically 23075 1Death Rates for HIV Patients Decrease Dramatically 23075 2Death Rates for HIV Patients Decrease Dramatically 23075 3Penn animal study identifies new DNA weapon against avian flu 23073 1Penn animal study identifies new DNA weapon against avian flu 23073 2Penn animal study identifies new DNA weapon against avian flu 23073 3Fungi the cause of many outbreaks of disease but mostly ignored 3851 1Fungi the cause of many outbreaks of disease but mostly ignored 3851 2Fungi the cause of many outbreaks of disease but mostly ignored 3851 3
...cience Closer to Targeted, Improved Therapies , BE...y the,National Institute on Drug Abuse (NIDA), par...he first time identified genes that,might increase...reakthrough research was conducted by Dr. George U...m led by Dr. Jed Rose at the,Center for Nicotine a...
...ril 02, 2007 /PRNewswire/ -- Berlex, Inc., a U.S.,...nounced today the,results of a retrospective study...ntibodies (NAbs) that can develop in response to,B...redict clinical,response in patients with multiple...over 6,600 patients across three continents. It,is...
Other Medicine Technology:NIDA Study Identifies Genes That Might Help Some People Abstain,from Smoking 2NIDA Study Identifies Genes That Might Help Some People Abstain,from Smoking 3Large Study Shows that Presence of Neutralizing Antibodies Did Not,Predict Clinical Response to Betaseron Treatment 2Large Study Shows that Presence of Neutralizing Antibodies Did Not,Predict Clinical Response to Betaseron Treatment 3Large Study Shows that Presence of Neutralizing Antibodies Did Not,Predict Clinical Response to Betaseron Treatment 4
... ARUP Laboratories is a national reference laborat...y research and development. ARUP offers an extensi...tests in clinical and anatomic pathology. Owned by...s include more than half of the nation's universit...
... ARUP Laboratories is a national reference laborat...y research and development. ARUP offers an extensi...tests in clinical and anatomic pathology. Owned by...s include more than half of the nation's universit...
... ARUP Laboratories is a national reference laborat...y research and development. ARUP offers an extensi...tests in clinical and anatomic pathology. Owned by...s include more than half of the nation's universit...
... ARUP Laboratories is a national reference laborat...y research and development. ARUP offers an extensi...tests in clinical and anatomic pathology. Owned by...s include more than half of the nation's universit...
Medicine Products: